Publications by authors named "H Ikehara"
Aim: This study aimed to compare the use of remimazolam and midazolam in upper gastrointestinal endoscopy in Japan as a sub-analysis of data from an investigator-initiated clinical trial of remimazolam.
Methods And Results: Patients in two groups were matched using propensity score matching. We evaluated the time from the end of the gastrointestinal endoscopy until discharge, the time from the end of the procedure until awakening, and adverse events.
Objectives: In gastroenterology, sedation demand is increasing, although elderly patients are more prone to experiencing adverse events. Remimazolam, a novel ultra-short-acting benzodiazepine, may reduce recovery time after endoscopic procedures.
Methods: This study was a secondary analysis of the investigator-initiated trial, which investigated the efficacy and safety of remimazolam in gastrointestinal endoscopy (REM-IICT JP01).
We read with great interest the recently published article by Amiri et al., titled "Medical, Dental, and Nursing Students' Attitudes and Knowledge Toward Artificial Intelligence: A Systematic Review and Meta-Analysis." We would like to offer comments on certain aspects of the findings that we believe warrant further discussion.
View Article and Find Full Text PDFArticle Synopsis
- The study investigated the effectiveness of Spray COAG for controlling bleeding during colorectal endoscopic submucosal dissection (ESD) compared to traditional methods.
- A total of 320 lesions were treated, with 307 included in the analysis; the use of Spray COAG began in April 2022.
- Results showed that using Spray COAG significantly reduced the need for hemostatic forceps and decreased the occurrence of a specific postoperative complication, while other complications remained unchanged.